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(A) Different mitochondrial shapes of mitochondria in HDC and LDC HeLa cells. A representative picture of cells
labeled for ER and mitochondria in HDC or LDC state HeLa cells. Cells expressing a mitochondrial targeting
variant of GFP (MT-GFP, green) and an ER targeting variant of DsRed (pDsRed2-ER, red) were used. Bar
lengths are of 10µm. (B) Mitochondrial size distribution in LDC or HDC state HeLa cells. Quantification based on
the images taken for cells in HDC and LDC states.

























(C) Live cell microscopy was done for a total of 3 mins at 1 fps. Representative frames of ER, EE and
mitochondria in LDC or HDC HeLa cells for depicted time periods are shown. Cells expressing a
mitochondrial targeting variant of GFP (MT-GFP green) and an ER targeting variant of DsRed,
(pDsRed2-ER, red) were used. Bars measure 10µm. The ROIs as depicted by square boxes are 10X
zoomed. Also see Movie 3 and 4. Arrowheads point dynamic mitochondria. Shown are the mean and
s.e.m for n>10. P values are calculated by Student’s t test, and three asterisks represent p values less
than 0.001. Arrows indicate mitochondria showing time dependent alteration in shape. (D) FRAP analysis
of GFP-positive mitochondria in HDC or LDC MDA-MB-231 cells. Cells expressing a mitochondrial
targeting variant of GFP (MT-GFP, green) were used. For indicated experimental sets, pre-FRAP and
post-FRAP frames at various time points are shown. MT-GFP was photobleached and The regions of
interest (ROI) are maked by circles. Among multiple ROIs used from the specific frame of HDC set, only
one has been elaborated for representation (indicated by white arrow). Scale bar 10 µm.
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Figure S2 Distribution of miRNP with different subcellular fractions in FCCP treated
mammalian cells
(A) Representative OptiPrep® gradient (3–30%) analysis of HeLa extracts of indicated
treatment by western blotting of specified proteins done with individual fractions. rRNA positions
are marked by * on a RNA profile picture (ethidium bromide stained gel) done for each fractions.
(B) Levels of miRNA let-7a (quantified by densitometry) in individual fractions of the Optiprep®.
from panel A were plotted. Let-7a levels in every individual fraction have been normalized
against the sum total of let-7a band intensity present in all the fractions. The resultant values
were fitted on a scale of 100 where “100” depicts the total sum of let-7a density for all the
f ti f i di id l i trac ons o an n v ua exper men .



























































































































Figure S3 Reduced P-body number, mitochondrial length and mitochondria-ER colocalization in
SH-SY5Y ρ0 cells
(A) Representative confocal images (left panel) depicting mitochondria (green) and ER (orange) in WT or
ρ0 SH-SY5Y cells. These were used to determine the line intensity profile (right panel) along an arbitrary
linear path (as depicted by dotted red line, left panel) whose starting direction has been shown by a white
arrow within the selected ROI. Arrows in the intensity profile indicate different areas of varied intensity
overlap. Cells co-expressing a mitochondrial targeting variant of GFP (MT-GFP, green) and an ER
targeting variant of DsRed (ER DsRed orange) were used in the merged panels of WT or ρ0 SH SY5Y- , -
cells in panel A. Scale bars 5 µm. (B) Left panel, mitochondrial length quantification was done for WT or ρ0
SH-SY5Y cells co-expressing a mitochondrial targeting variant of GFP (MT-GFP) using Imaris sofware for
n>25 cells. Right panel, mitochondria-ER colocalization was estimated using Mander’s colocalization
coefficient based quantification between MT-GFP and ER-DsRed for WT or ρ0 SH-SY5Y cells for n>30
cells. (C) Estimation of endogenous Dcp1a, GW182, Rck/p54 and Xrn1 positive body numbers determined
from confocal image frames of WT or ρ0 SH-SY5Y cells labelled for the individual p-body markers by
immunofluorescence and were normalized against number of cells for n>20 cells. P values are calculated
by Student’s t test and three asterisks represent p values less than 0 001 Shown are the mean and s e m, . . . .
from at least three independent experiments.







































































































Figure S4 Characteristics of P-Bodies changes with cell confluency.
(A) FRAP analysis from HDC or LDC cells (n>4, each) transfected with a GFP tagged variant of Ago2 or
Dcp1a for indicated experimental sets was done. GFP tagged proteins was photobleached and Images
were acquired at 1 frame per second for 500 seconds. The mean percent intensity values of different
regions of interest (ROI) thus obtained was plotted. (B) Cells transfected with a GFP tagged variant of Ago2
(Ago2-GFP, green) for indicated experimental sets were used. Ago2-GFP live cell images were acquired at
1 frame per second for 500 seconds. Particle Tracking was used to determine the path and speed of the
Ago2-GFP bodies. (C) Cells transfected with a GFP tagged variant of Ago2 (Ago2-GFP, green) for
indicated experimental sets were used. Ago2-GFP fixed cell images were used for calculating the diameter
of Ago2-GFP bodies in HeLa HDC or LDC cells. P values are calculated by Student’s t test, two and three
asterisks represent p values less than 0.01 and 0.001 respectively. Shown are the mean and s.e.m from at
least three independent experiments.









































































































Figure S5 Restoration of mitochondrial membrane potential rescues miRNP trafficking and P-bodies.
(A) Representative plots using flow cytometry based quantification of JC-1 staining of LDC, HDC and 3 hrs of 100µM genipin
treated HDC HeLa cells Percent of cells in P3 zone (low JC 1 Fluorescence green) were measured and shown as depicted. - , .
(B) Representative confocal images depicting P-bodies in HDC HeLa cells and HDC HeLa cells treated with Genipin. Indirect
immunofluorescence was used to detect endogenous Ago2 (green) and RCK/p54 (red). Bars measure 10µm. DAPI was used
for depicting nuclei. The ROIs as depicted are zoomed 5 times. (C) Estimation of numbers of Ago2-positive bodies was done
for HDC HeLa or HDC HeLa cells treated with Genipin as shown in the representative images in analysis of indicated
proteins. (D) The effect of Genipin on Ago2 and Ucp2 protein levels in HDC MDA-MB-231 cells. Representative western
blots are shown. (E) qRT-PCR based relative quantification of endogenous let-7a levels in fractions obtained from one-step
polysome separation gradients done with HDC or LDC MDA-MB-231 cells of indicated Genipin treatment. Values were
normalized against respective miRNA levels in LDC cells and shown. Shown are the mean and s.e.m from at least three
independent experiments (F) qRT PCR based quantification of changes in EV associated miRNA levels following exposure. - -
to Genipin. Ct values of endogenous miRNA levels in HDC or LDC MDA-MB-231 cells after Genipin treatment. p values are
calculated by Student’s t test, and one and three asterisks represent p values less than 0.05, and 0.001, respectively.















































































































expression of the mTORC1 activator protein Myc-Rheb enhances eIF4E targeting to microsomes and reduced
polysomal accumulation of miRNAs.
(A,B) Effect of treatment of UPR activator Thapsigargin (TSG) on PERK activation and inactivation of mTORC1 and its
downstream molecules in MEF cells. Western blot data shows differential cellular enrichment of p-PERK, different translation
factors (eIF4E, p-eIF4E-BP1, p-S6K and p-eIF2α) and p-mTOR after 2.5 μM of Thapsigargin treatment of MEF cells for 16 h.
Immunoblot data of microsomes also showed enrichment of eIF4E, p-eIF2α and eIF4E-BP1 in Thapsigargin-treated cells. β-
Actin or Calnexin were used as loading control for total or microsomal fractions respectively. (C) Increased cellular and
microsomal enrichment of Activated AMPK in HDC cells. Western blot data reveals increased p-AMPK status on HDC state
cells compared with LDC state of MDA-MB-231 cells. (D, E) Treatment of AMPK inhibitor Dorsomorphin increases mTORC1
activation in HDC state MDA-MB-231 cells but without restoration eIF4E level in microsomal fraction. Western blot data shows
cellular and microsomal enrichment of different translation factors (eIF4E, p-eIF4E-BP1, p-S6K), p-mTOR and AMPK after 10
μM of Dorsomorphin treatment for 2 hours. DMSO used for control. β Actin or Calnexin were used as loading control for total
or microsomal fractions respectively. (F,G) Cellular and microsomal enrichment of different translation factors (eIF4E, p-
eIF4E-BP1, p-S6K and p-eIF2α) and mTORC1 complex proteins (P-mTOR, Raptor) after overexpression of c-Myc-Rheb on
MDAM-MB-231 cells. Proteins samples from total or microsomal fractions were analyzed by western blotting. β Actin or
Calnexin were used as loading control for total or microsomal fractions respectively. For control set we used pCIneo vector to
transfect. (H) Increased polysomal enrichment of eIF-4E on c-Myc-Rheb over expressed MDAM-MB-231 cells. Ribosomal
protein S3 serves as an endogenous control. (I, J) Quantitative RT-PCR based analysis reveals reduced cellular and
polysomal association of let-7a after overexpression of c-Myc-Rheb on MDAM-MB-231 cells. U6snRNA served as an internal
control. Paired two-tailed Student’s t tests were used for all comparisons. p < 0.05 (*); p < 0.01 (**). In (I-J) values are means
from at least three biological replicates ± SD.

























Movie 1 Mitochondrial movements in MDA-MB-231 LDC cells. 
Time lapse imaging of Mitochondria and ER in MDA-MB-231 LDC cells imaged for 1 frame 
per second for 115 frames. Cells have been co-transfected with pDsRed2-ER (red) and 
pAcGFP1-Mito (green) plasmids. The video plays at 5 frames per second. Scale bars, 
10 μm. Time is in hours:minutes:seconds. Also see Figure 1C. 
Movie 2 Mitochondrial movements in MDA-MB-231 HDC cells. 
Time lapse imaging of Mitochondria and ER in MDA-MB-231 HDC cells imaged for 1 frame 
per second for 115 frames. Cells have been co-transfected with pDsRed2-ER (red) and 
pAcGFP1-Mito (green) plasmids. The video plays at 5 frames per second. Scale bars, 
10 μm. Time is in hours:minutes:seconds. Also see Figure 1C. 

























Movie 3 Mitochondrial movements in HeLa LDC cells. 
Time lapse imaging of Mitochondria and ER in HeLa LDC cells imaged for 1 frame 
per second for 115 frames. Cells have been co-transfected with pDsRed2-ER (red) and 
pAcGFP1-Mito (green) plasmids. The video plays at 5 frames per second. Scale bars, 
10 μm. Time is in hours:minutes:seconds. Also see Figure S1C. 
Movie 4 Mitochondrial movements in HeLa HDC cells. 
Time lapse imaging of Mitochondria and ER in HeLa HDC cells imaged for 1 frame 
per second for 115 frames. Cells have been co-transfected with pDsRed2-ER (red) and 
pAcGFP1-Mito (green) plasmids. The video plays at 5 frames per second. Scale bars, 
10 μm. Time is in hours:minutes:seconds. Also see Figure S1C. 

























Movie 6 FRAP analysis of GFP-positive mitochondria in HDC MDA-MB-231 cells.  
Cells expressing a mitochondrial targeting variant of GFP (MT-GFP, green) were used. 
FRAP analysis from 100 cells (n>4) for indicated experimental sets. MT-GFP was 
photobleached and images were acquired at 2 frames per second.  
Movie 5 FRAP analysis of GFP-positive mitochondria in LDC MDA-MB-231 cells.  
Cells expressing a mitochondrial targeting variant of GFP (MT-GFP, green) were used. 
FRAP analysis from 100 cells (n>4) for indicated experimental sets. MT-GFP was 
photobleached and images were acquired at 2 frames per second.  

























 Table S1. List of Antibodies 
Name of Antigen Raised in Dilution (WB) Dilution (IF) Source 
Ago2 (eIF2C2) Mouse 1:1000 1:100 Abnova 
HA Rat 1:1000 1:100 Roche 
HRS Rabbit 1:2000 - Bethyl 
Calnexin Rabbit 1:10000 - Bethyl 
β-Actin HRP-conjugated 1:10000 - Sigma Aldrich 
GW182 Rabbit - 1:400 Bethyl 
Alix Mouse 1:100 - Santa Cruz 
CD-63 Mouse 1:500 - BD Biosciences
DDX6 /RCK/p54 Rabbit 1:10000 1:1000 Bethyl 
Rab5 Rabbit - 1:100 Cell Signalling 
Grp-78/Bip-1 Rabbit 1:2000 - Millipore 
Cox-IV Rabbit 1:1000 - Cell Signalling 
Ucp2 Rabbit 1:4000 - Novus 
XRN1 Rabbit 1:10000 1:1000 Bethyl 
cMyc Mouse 1:500 1:100 SantaCruz 
Dcp-1a Mouse 1:1000 1:100 Novus 
VDAC Rabbit 1:2000 - Sigma Aldrich 
Ribosomal S3 Rabbit 1:1000 - Cell Signalling 
eIF-4E Rabbit 1:10000 1:1000 Bethyl 
P-eIF-4EBP1 Rabbit 1:1000 - Cell Signaling 
P-eIF-2α Rabbit 1:1000 - Cell Signaling 
eEF2 Rabbit 1:10000 - Bethyl 
eIF-2α Rabbit 1:1000 - Cell Signaling 
mTOR Rabbit 1:1000 - Cell Signaling 
P-mTOR Rabbit 1:1000 - Cell Signaling 



























Ribosomal L7a Rabbit 1:1000 - Cell Signaling 
eIF-4E-T Rabbit 1:8000 - Bethyl 
Dicer Rabbit 1:5000 - Bethyl 
Rictor Mouse 1:1000 - Sigma 
β‐Tubulin Mouse 1:1000 - SIGMA 
AMPK  Rabbit  1:1000 - Cell Signaling
P‐AMPK  Rabbit  1:1000 - Cell Signaling
PERK  Rabbit  1:1000 - Cell Signaling
P‐PERK  Rabbit  1:1000 - Cell Signaling
S6‐K  Rabbit  1:1000 - Cell Signaling
P‐S6‐K  Rabbit  1:1000 - Cell Signaling 
J. Cell Sci.: doi:10.1242/jcs.250241: Supplementary information
Jo
ur
na
l o
f C
el
l S
ci
en
ce
 •
 S
up
pl
em
en
ta
ry
 in
fo
rm
at
io
n
